Sheel Biotech Ltd

NSE: SHEEL

₹46.70

up-down-arrow2.10 (4.71%)

As on 04-Jun-2026IST

Market cap

info icon

₹95 Cr

Revenue (TTM)

info icon

₹102 Cr

P/E Ratio

info icon

8.1

P/B Ratio

info icon

1.1

Div. Yield

info icon

0 %

Sheel Biotech Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 46.00 High: 46.80

52 Week Range

Low: 37.80 High: 95.55

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹11 Cr

  • ROEROE information

    13.6 %

  • ROCEROCE information

    14.8 %

  • Industry P/EIndustry P/E information

    19.28

  • EV/EBITDAEV/EBITDA information

    6.6

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹56.1

  • EPSEPS information

    ₹7.1

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    20,352,550

10 Years Aggregate

CFO

₹25.41 Cr

EBITDA

₹89.39 Cr

Net Profit

₹62.77 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sheel Biotech
-34.2 0.1 -15.2 -- -- -- --
BSE FMCG
-11.3 -5.3 -3.6 -12.1 -0.8 6.4 8.1
As on 04-Jun-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Sheel Biotech
46.7 95.1 101.8 10.6 -- 13.6 8.1 1.1
1,126.4 15,349.4 6,067.3 657.0 11.3 19.5 25.3 4.7
119.3 237.6 28.2 7.6 -- 20.3 22.7 2.9
18.0 9.9 4.8 -0.5 -10.0 -12.8 -- 2.8
2.7 5.9 0.0 0.3 -- 1.2 22.1 0.3
26.7 247.5 261.6 12.8 8.6 5.6 19.3 1.1
1.6 5.9 0.9 0.0 -3.2 -- 42.1 0.1
6.9 28.6 146.2 0.9 1.0 5.1 32.2 1.2
99.8 25.8 3.3 1.7 -- 26.2 12.8 2.4
32.1 19.9 25.5 1.8 -- 8.1 11.2 0.7

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Sheel Biotech

--

  • Incorporated

    1991

  • Chairman

    Satya Narayan Chandak

  • Managing Director

    Divye Chandak

  • Headquarters

    New Delhi, Delhi

  • Website

    www.sheelbiotech.com

Edit peer-selector-edit
loading...
loading...

Announcements

View Announcements

No News & Announcements are available.

FAQs for Sheel Biotech

The share price of Sheel Biotech Ltd is ₹46.70 (NSE) as of 04-Jun-2026 IST. Sheel Biotech Ltd has given a return of --% in the last 1 years.

The P/E ratio of Sheel Biotech Ltd is 8.08 times as on 04-Jun-2026, a 58 discount to its peers’ median range of 19.28 times.
The P/B ratio of Sheel Biotech Ltd is 1.06 times as on 04-Jun-2026, a 9 discount to its peers’ median range of 1.17 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Sheel Biotech Ltd are Rs 95.55 and Rs 37.80 as of 05-Jun-2026.

Sheel Biotech Ltd has a market capitalisation of ₹ 95 Cr as on 04-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Sheel Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.